Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project

Background The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to improve the availability and standardization of data on hematologic malignancies in Europe, used the European Cancer Registry-based project on survival and care of cancer patients (EUROCARE-4) da...

Descripción completa

Detalles Bibliográficos
Autores: Marcos-Gragera, R, Allemani, C, Tereanu, C, De Angelis, R, Capocaccia, R, Maynadie, M, Luminari, S, Ferretti, S, Johannesen, TB, Sankila, R, Karjalainen-Lindsberg, ML, Simonetti, A, Martos, MC, Raphael, M, Giraldo, P, Sant, M
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2011
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p14150
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/14150
Access Level:acceso abierto
Palabra clave:lymphoid malignancies
survival
outcome
id ES_7f0d83fd3efa2ed5cad70b4fa0e68493
oai_identifier_str oai:fisabio.fundanetsuite.com:p14150
network_acronym_str ES
network_name_str España
repository_id_str
spelling Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE projectMarcos-Gragera, RAllemani, CTereanu, CDe Angelis, RCapocaccia, RMaynadie, MLuminari, SFerretti, SJohannesen, TBSankila, RKarjalainen-Lindsberg, MLSimonetti, AMartos, MCRaphael, MGiraldo, PSant, Mlymphoid malignanciessurvivaloutcomeBackground The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to improve the availability and standardization of data on hematologic malignancies in Europe, used the European Cancer Registry-based project on survival and care of cancer patients (EUROCARE-4) database to produce a new grouping of hematologic neoplasms (defined by the International Classification of Diseases for Oncology, Third Edition and the 2001/2008 World Health Organization classifications) for epidemiological and public health purposes. We analyzed survival for lymphoid neoplasms in Europe by disease group, comparing survival between different European regions by age and sex. Design and Methods Incident neoplasms recorded between 1995 to 2002 in 48 population-based cancer registries in 20 countries participating in EUROCARE-4 were analyzed. The period approach was used to estimate 5-year relative survival rates for patients diagnosed in 2000-2002, who did not have 5 years of follow up. Results The 5-year relative survival rate was 57% overall but varied markedly between the defined groups. Variation in survival within the groups was relatively limited across European regions and less than in previous years. Survival differences between men and women were small. The relative survival for patients with all lymphoid neoplasms decreased substantially after the age of 50. The proportion of 'not otherwise specified' diagnoses increased with advancing age. Conclusions This is the first study to analyze survival of patients with lymphoid neoplasms, divided into groups characterized by similar epidemiological and clinical characteristics, providing a benchmark for more detailed analyses. This Europe-wide study suggests that previously noted differences in survival between regions have tended to decrease. The survival of patients with all neoplasms decreased markedly with age, while the proportion of 'not otherwise specified' diagnoses increased with advancing age. Thus the quality of diagnostic work-up and care decreased with age, suggesting that older patients may not be receiving optimal treatment.FERRATA STORTI FOUNDATION2011info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/14150HAEMATOLOGICAISSN: 03906078ISSNe: 15928721reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p141502026-06-11T12:45:17Z
dc.title.none.fl_str_mv Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
title Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
spellingShingle Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
Marcos-Gragera, R
lymphoid malignancies
survival
outcome
title_short Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
title_full Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
title_fullStr Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
title_full_unstemmed Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
title_sort Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
dc.creator.none.fl_str_mv Marcos-Gragera, R
Allemani, C
Tereanu, C
De Angelis, R
Capocaccia, R
Maynadie, M
Luminari, S
Ferretti, S
Johannesen, TB
Sankila, R
Karjalainen-Lindsberg, ML
Simonetti, A
Martos, MC
Raphael, M
Giraldo, P
Sant, M
author Marcos-Gragera, R
author_facet Marcos-Gragera, R
Allemani, C
Tereanu, C
De Angelis, R
Capocaccia, R
Maynadie, M
Luminari, S
Ferretti, S
Johannesen, TB
Sankila, R
Karjalainen-Lindsberg, ML
Simonetti, A
Martos, MC
Raphael, M
Giraldo, P
Sant, M
author_role author
author2 Allemani, C
Tereanu, C
De Angelis, R
Capocaccia, R
Maynadie, M
Luminari, S
Ferretti, S
Johannesen, TB
Sankila, R
Karjalainen-Lindsberg, ML
Simonetti, A
Martos, MC
Raphael, M
Giraldo, P
Sant, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv lymphoid malignancies
survival
outcome
topic lymphoid malignancies
survival
outcome
description Background The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to improve the availability and standardization of data on hematologic malignancies in Europe, used the European Cancer Registry-based project on survival and care of cancer patients (EUROCARE-4) database to produce a new grouping of hematologic neoplasms (defined by the International Classification of Diseases for Oncology, Third Edition and the 2001/2008 World Health Organization classifications) for epidemiological and public health purposes. We analyzed survival for lymphoid neoplasms in Europe by disease group, comparing survival between different European regions by age and sex. Design and Methods Incident neoplasms recorded between 1995 to 2002 in 48 population-based cancer registries in 20 countries participating in EUROCARE-4 were analyzed. The period approach was used to estimate 5-year relative survival rates for patients diagnosed in 2000-2002, who did not have 5 years of follow up. Results The 5-year relative survival rate was 57% overall but varied markedly between the defined groups. Variation in survival within the groups was relatively limited across European regions and less than in previous years. Survival differences between men and women were small. The relative survival for patients with all lymphoid neoplasms decreased substantially after the age of 50. The proportion of 'not otherwise specified' diagnoses increased with advancing age. Conclusions This is the first study to analyze survival of patients with lymphoid neoplasms, divided into groups characterized by similar epidemiological and clinical characteristics, providing a benchmark for more detailed analyses. This Europe-wide study suggests that previously noted differences in survival between regions have tended to decrease. The survival of patients with all neoplasms decreased markedly with age, while the proportion of 'not otherwise specified' diagnoses increased with advancing age. Thus the quality of diagnostic work-up and care decreased with age, suggesting that older patients may not be receiving optimal treatment.
publishDate 2011
dc.date.none.fl_str_mv 2011
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/14150
url https://fisabio.portalinvestigacion.com/publicaciones/14150
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv FERRATA STORTI FOUNDATION
publisher.none.fl_str_mv FERRATA STORTI FOUNDATION
dc.source.none.fl_str_mv HAEMATOLOGICA
ISSN: 03906078
ISSNe: 15928721
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411795394887680
score 15,812429

Similares en LA Referencia